Fig. 8.
Fig. 8. Lack of NFκB activation in response to EPO. / DP16.1/p53ts cells were left untreated (lane 1), were treated with EPO for 15 minutes (lane 2), or were treated with TNF-α (20 ng/mL) for 15 minutes (lane 3) or 30 minutes (lane 4). NFκB activation was determined using a gel mobility shift assay.

Lack of NFκB activation in response to EPO.

DP16.1/p53ts cells were left untreated (lane 1), were treated with EPO for 15 minutes (lane 2), or were treated with TNF-α (20 ng/mL) for 15 minutes (lane 3) or 30 minutes (lane 4). NFκB activation was determined using a gel mobility shift assay.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal